CRASH 3: TXA is no wonder drug

TXA has been the darling drug of emergency medicine and critical care since the publication of the CRASH 2 trial back in 2010. CRASH 2 demonstrated a 1.5% decrease in mortality when TXA was given to trauma patients with significant bleeding. (CRASH 2 2010) These results led to the widespread adoption of TXA in trauma … Continue reading CRASH 3: TXA is no wonder drug